Tag Archives: ZGNX

Zogenix (ZGNX) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $65.00. The company’s shares closed last Monday at $42.41. According to TipRanks.com, Yang is a 3-star analyst with

Wednesday’s Midday Stock Update: Merrimack Pharmaceuticals (MACK), Rite Aid Corp (RAD), Novavax (NVAX), La Jolla Pharma (LJPC), Zogenix (ZGNX)

So far Wednesday, September 11, NASDAQ is up 2.75% and the S&P is up 1.33%. Here are this morning’s most active stocks: Merrimack Pharmaceuticals (MACK – Research Report), Rite Aid Corp (RAD – Research Report), Novavax (NVAX – Research Report),

Analysts Are Bullish on Top Healthcare Stocks: Zogenix (ZGNX), Stryker Corporation (SYK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zogenix (ZGNX – Research Report), Stryker Corporation (SYK – Research Report) and Global Blood Therapeutics (GBT – Research Report) with bullish sentiments.

Zogenix (ZGNX) Received its Third Buy in a Row

After Mizuho Securities and Stifel Nicolaus gave Zogenix (NASDAQ: ZGNX) a Buy rating last month, the company received another Buy, this time from Northland Securities. Analyst Carl Byrnes maintained a Buy rating on Zogenix today and set a price target

Northland Securities Remains a Buy on Zogenix (ZGNX)

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $60. The company’s shares closed yesterday at $47.48. Byrnes observed: “We are reiterating our OP

Northland Securities Keeps a Buy Rating on Zogenix (ZGNX)

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $60. The company’s shares closed on Friday at $47.72. Byrnes wrote: “We note that 1504